CALL/MERCK & CO./120/0.1/21.06.24 | Real-time BOERSE MUENCHEN 10:27:25 2024-06-19 EDT | ||
| 0.75 EUR | -4.70% |
|
| Current month | +38.07% | ||
| 1 month | -26.31% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
| Date | Price | Change |
|---|---|---|
| 24-06-19 | 0.75 | -4.70% |
| 24-06-18 | 0.787 | +6.64% |
| 24-06-17 | 0.738 | -15.66% |
| 24-06-14 | 0.875 | -0.46% |
| 24-06-13 | 0.879 | -11.48% |
Real-time BOERSE MUENCHEN
Last update June 19, 2024 at 10:27 am
More quotesStatic data
| Product type | Plain-Vanilla-Warrants |
|---|---|
| Buy / Sell | CALL |
| Underlying | MERCK & CO., INC. |
| Issuer | Goldman Sachs |
| WKN | GK703W |
| ISIN | DE000GK703W4 |
| Date issued | 2022-07-04 |
| Strike | 120 $ |
| Maturity | 2024-06-21 (2 Days) |
| Parity | 10 : 1 |
| Emission price | 0.35 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.4 € |
|---|---|
| Lowest since issue | 0.082 € |
| Spread | 0.03 € |
| Spread % | 4.00% |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
128
USD
Average target price
142.7
USD
Spread / Average Target
+11.48%
- Stock Market
- Warrants
- Warrant
